サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：神経モニタリングシステムの世界市場-2023年～2030年
市場調査レポート
商品コード
1345438

神経モニタリングシステムの世界市場-2023年～2030年

Global Nerve Monitoring Systems Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 186 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
神経モニタリングシステムの世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界の神経モニタリングシステム市場は、2022年に14億米ドルに達し、2023-2030年の予測期間中にCAGR 5.6％で成長し、2030年には54億米ドルに達すると予測されています。

術中神経モニタリング（IOM）は、外科医が外科手術中に神経の機能をモニタリングしコントロールすることを可能にします。神経外科手術や脊髄手術が必要な場合、治療の標準となっている先端技術機器の使用が必要となります。術中神経モニタリングシステムは、外科医が運動神経機能を特定・確認・監視することを可能にし、耳鼻咽喉科や一般外科を含む様々な手術中の神経損傷のリスクを軽減するのに役立ちます。

さらに、世界の神経モニタリングシステム市場は、神経関連疾患の症例の増加、AIの搭載などの進歩の増加、主要企業による製品上市の増加、Medtronic、Nuvasive、日本光電工業、CheckPoint Surgicalsなどの重要な主要企業を有する他社との提携や買収など、さまざまな要因によって牽引されています。

ダイナミクス

外傷症例における神経モニタリングの使用増加

外傷症例における神経モニタリング使用の増加は、予測期間中の市場成長を後押しする重要な要因の1つです。瘢痕組織の剥離の補助として術中神経モニタリング（IONM）を使用することで、神経損傷のリスクを最小限に抑えられると考えられています。これらのシステムは外科医が神経の機能的完全性を知るのに役立ち、実際にこれらのシステムの使用は市場で増加しています。

例えば、2021年4月、Penn MedicineはPenn Nerve Centerを立ち上げ、外傷性神経損傷、神経巻き込み、神経圧迫、神経腫瘍など、幅広い神経疾患に対して専門的な診断と最先端の治療を提供するために、分野を超えた専門家を結集しました。

神経モニタリングシステムの進歩

神経モニタリングシステムの進歩は、予測期間中に市場が成長するための重要な要因の1つです。これらの進歩は、外科医が神経の位置を正確に特定しモニターするのに役立ち、外科手術中の患者へのダメージを軽減します。神経モニタリングシステムにはいくつかの進歩が統合されており、その1つが機械学習です。神経モニタリングの効率と信頼性は、MLモデルの使用によって向上します。ニューラルネットワーク、人工ニューラルネットワーク、畳み込みニューラルネットワークなど、さまざまな機械学習モデルがあります。

例えば、2022年3月、韓国科学技術院（KAIST）の研究者は、腕の運動中の脳からの神経信号を解読する読心システムを開発しました。このシステムは脳波（EEG）と皮質電位（ECoG）技術を使用します。

ECoGは主にてんかん発作の潜在的な原因を見つけるために使用されます。つまり、電極は患者ごとに異なる場所に設置され、感覚信号や運動信号の検出に最適な脳の領域にあるとは限らないです。

こうした問題を克服するため、チョン教授の研究チームは、腕の運動中のECoG神経信号を解読する新しい方法を開発しました。このシステムは、「エコー状態ネットワーク」と呼ばれる神経信号を分析・予測するための機械学習システムと、ガウス分布と呼ばれる数学的確率モデルに基づいています。

製品上市の増加

製品上市の増加は、予測期間中に市場が成長するための重要な要因の1つです。例えば、2021年6月、衰弱性慢性疼痛に苦しむ患者の疼痛緩和の改善に注力する医療機器企業であるNeuraLace Medical, Inc.は、末梢神経を非侵襲的に刺激し、慢性神経の疼痛緩和を提供するAxon TherapyのFDA 510（k）認可を取得したことを本日発表しました。

事業提携・拡大・買収などの戦略的イニシアチブも市場の大幅な成長につながる

例えば、2022年4月、Assure Holdings Corp.はConductive社と術中神経モニタリングサービスのグループ購買契約（「GPO」）を締結しました。この契約により、500の病院や手術センター、50以上の医療システムを含むConductiveの会員は、Joint Commissionに認定されたAssureの術中神経モニタリングサービスの特別価格と事前交渉による条件を利用できるようになっています。

医療専門家における神経モニタリングの認知度の低さ

神経モニタリング装置はより複雑になり、広範な装置知識を必要とします。多くの新しい基本ソフトウェアが神経モニタリング装置と統合されていますが、神経生理学的モニタリングの基本的理解が不足しているため、誤解や技術的課題が悪化する可能性があります。未開発国や新興国において、これらの機器を効果的に使用するためには、より多くの専門家が必要です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 外傷症例における神経モニタリングの使用事例の増加
      • 神経モニタリングシステムの進歩
      • 製品上市の増加
      • 事業提携・拡張・買収などの戦略的イニシアチブも市場の大幅な成長につながる
    • 抑制要因
      • 医療専門家における神経モニタリングの認知度の低さ
    • 機会
      • 神経関連疾患の症例の増加
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品タイプ別

  • モニター
  • 刺激装置
  • 神経モニタリング電極
  • プローブ

第8章 技術別

  • 誘発電位（EP）
  • 筋電図（EMG）
  • 脳波（EEG）
  • 皮質電気泳動（ECOG）

第9章 用途別

  • 脳神経外科
  • 脊椎外科
  • 耳鼻咽喉科
  • 心血管用途
  • その他の用途

第10章 エンドユーザー別

  • 病院
  • 外科センター
  • 外来手術センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Medtronic
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Nuvasive
  • NihonKohden
  • CheckPoint Surgicals
  • Natus
  • Inomed
  • Magstim
  • Neurowave Systems
  • Axontronic
  • Xavant Technologies

第14章 付録

目次
Product Code: MD6788

Overview

Global Nerve Monitoring Systems Market reached US$ 1.4 billion in 2022 and is expected to reach US$ 5.4 billion by 2030, growing with a CAGR of 5.6% during the forecast period 2023-2030.

Intraoperative nerve monitoring (IOM) enables surgeons to monitor and control the function of the nerves during a surgical procedure. When neurosurgery and spinal surgery are required, this entails the use of advanced technology equipment that has become the standard of treatment. Intraoperative nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT and general surgeries.

Furthermore, the global nerve monitoring systems market is driven by various factors like an increase in the cases of nerve-related disorders, a rise in advancements like the inclusion of AI, a rise in product launches by key players, collaboration and acquisition with other companies and others having significant key players like Medtronic, Nuvasive, NihonKohden, CheckPoint Surgicals and others.

Dynamics

Rising Use of Nerve Monitoring in Trauma Cases

The rise in the use of nerve monitoring in trauma cases is one of the key factors that helps the market to grow during the forecast period. The use of intraoperative nerve monitoring (IONM) as an aid in dissection of the scar tissue is believed to minimize the risk of nerve injury. These systems help surgeons to know the functional integrity of nerves and indeed the use of these systems rises in the market.

For instance, in April 2021 Penn Medicine launched the Penn Nerve Center, which unites experts across disciplines to offer expert diagnosis and cutting-edge treatment for a wide range of nerve conditions including traumatic nerve injuries, nerve entrapment, nerve compression, and nerve tumours.

Advancements in Nerve Monitoring Systems

Advancements in Nerve Monitoring Systems are one of the key factors that help the market to grow during the forecast period. These advancements help the surgeons to accurately locate and monitor the nerves which indeed reduces the damage to the patient during the surgical procedures. Several advancements have been integrated into the nerve monitoring systems one of them was Machine learning. The efficiency and reliability of nerve monitoring will be enhanced with the use of ML models. There are various machine learning models like Neural Networks, Artificial Neural Networks, Convolutional Neural Networks and many more.

For instance, in March 2022, Researchers from the Korea Advanced Institute of Science and Technology (KAIST) developed a mind-reading system for decoding neural signals from the brain during arm movement. This system uses electroencephalography (EEG) and electrocorticography (ECoG) techniques.

The ECoG is primarily used to find potential sources of epileptic seizures, meaning the electrodes are placed in different locations for different patients and may not be in the optimal regions of the brain for detecting sensory and movement signals.

To overcome these problems, Professor Jeong's team developed a new method for decoding ECoG neural signals during arm movement. The system is based on a machine-learning system for analyzing and predicting neural signals called an 'echo-state network' and a mathematical probability model called the Gaussian distribution.

Rise In the Product Launches

Rise in the product launches is one of the key factors that helps the market to grow during the forecast period. For instance, in June 2021, NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today that it has received FDA 510(k) clearance for Axon Therapy to non-invasively stimulate peripheral nerves and provide chronic nerve pain relief.

Strategic Initiatives Such as Partnerships, Expansions, And Acquisitions Will Also Lead to Significant Market Growth.

For instance, in April 2022, Assure Holdings Corp. entered into a group purchasing agreement ("GPO") for intraoperative neuromonitoring services with Conductive. The agreement allows Conductive members, which includes 500 hospitals and surgery centers and more than 50 health systems, to take advantage of special pricing and pre-negotiated terms for Assure's Joint Commission-accredited intraoperative neuromonitoring services.

Limited Awareness About Nerve Monitoring Among Healthcare Professionals

Nerve monitoring devices become more complex, requiring extensive device knowledge. Many new fundamental software is integrated with nerve monitoring devices, but misunderstandings and technical challenges may worsen due to a lack of fundamental understanding of neurophysiological monitoring. More professionals are needed in undeveloped or emerging countries to effectively use these devices.

Segment Analysis

The global nerve monitoring systems market is segmented based on product type, technology, application, end-user and region.

The Neurosurgery Segment From The Application Segment Accounted For Approximately 43.7% of Nerve Monitoring Systems Share

The neurosurgery segment from the application segment accounted for 43.7% and it is expected to be dominated during the forecast period. There is a growing burden of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, Huntington's disease, and motor neuron diseases, among others, in the older population across the world. Thus, this leads to progressive neural dysfunction and toxicities, increasing the demand for effective nerve modulation devices, thereby driving growth in the studied market. Thus, with the increasing geriatric population, the burden of neurological diseases may increase and boost the segment's growth during the forecast period.

For instance, according to Alzheimer's Association updated factsheet 2023 An estimated 6.7 million Americans age 65 and older are living with Alzheimer's dementia in 2023. Seventy-three percent are age 75 or older of the total U.S. population. About 1 in 9 people (10.8%) age 65 and older have Alzheimer's dementia. Hence Due to the increasing burden of Alzheimer's Disease, brain surgeries are expected to increase, creating the need for a nerve monitoring system over time.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors like these devices are majorly used in a variety of surgical disciplines, such as otolaryngology, spine surgery, and neurosurgery, FDA Clearance, real-time data from nerve monitoring equipment during surgeries increases surgical accuracy and lowers the chance of nerve injury. As technology is developing, monitoring systems have become more sophisticated and user-friendly, luring healthcare providers to invest in these solutions.

In addition, as these systems are essential for the diagnosis and management of such problems, the rising frequency of chronic neurological disorders, and an ageing population contribute to the revenue growth of the market in this region.

In April 2023, Neuspera Medical, a medical device company developing implantable devices for patients battling chronic illnesses, announced it received U.S. Food and Drug Administration (FDA) clearance for the next-generation Neuspera ultra-miniaturized system. The system is comprised of a micro-implant that delivers neurostimulation therapy through a wireless platform including a wearable transmitter and iPad-based clinician programmer.

Competitive Landscape

The major global players in the market include: Medtronic, Nuvasive, NihonKohden, CheckPoint Surgicals, Natus, Inomed, Magstim, Neurowave Systems, Axontronic, Xavant Technologies and among others.

COVID-19 Impact Analysis

COVID had a substantial impact on the global nerve monitoring systems market during the current pandemic COVID-19 is a newly widespread virus with a high infection rate many individuals have faced heart-related issues and brain which indeed resulted in some surgeries at peak stages hence due to the increased number of patients with limited hospital facilities in many parts of the world. Since need for Non-invasive monitoring of individuals with COVID-19 can help triage by monitoring at-risk persons and assessing the need for invasive monitoring modalities.

By Product Type

  • Monitors
  • Stimulation Devices
  • Nerve Monitoring Electrodes
  • Probes

By Technology

  • Evoked Potential(EP)
    • Somatosensory Evoked Potential (SSEP)
    • Motor Evoked Potential (MEP)
    • Visual Evoked Potential (VEP)
    • Brainstem Auditory Evoked Potential (BAEP)
  • Electromyography (EMG)
  • Electroencephalography (EEG)
  • Electrocorticography (ECOG)

By Application

  • Neurosurgery
  • Spine Surgery
  • ENT Surgery
  • Cardiovascular Applications
  • Other Applications

By End User

  • Hospitals
  • Surgical Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In March 2021 Neurosign gained FDA clearance for the V4 4-channel and 8-channel nerve monitoring system and it is already being used on patients for nerve identification and preservation in the USA. Dr. Jeffson Chung, a surgeon and Assistant Professor of Otolaryngology, and Director of QI and Safety, at West Virginia University Hospital, recently used the V4 in successful thyroidectomy and facial nerve surgeries. For nerve identification and stimulation, Dr. Chung used the Neurosign Bipolar probe.
  • In October 2020 Medtronic plc the global leader in medical technology, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables physicians to identify, confirm, and monitor nerve function to help reduce the risk of nerve damage during head and neck surgery.1 The NIM Vital system uses proprietary technology to provide detailed intraoperative nerve condition data that informs surgical strategy,2 increases operative efficiency and precision,3 and helps protect patients' quality of life.

Why Purchase the Report?

  • To visualize the global nerve monitoring systems market segmentation based on product type, technology, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global nerve monitoring systems market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Global Nerve Monitoring Systems Market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Use of Nerve Monitoring in Trauma Cases
      • 4.1.1.2. Advancements in Nerve Monitoring Systems
      • 4.1.1.3. Rise In the Product Launches
      • 4.1.1.4. Strategic Initiatives Such as Partnerships, Expansions, And Acquisitions Will Also Lead To Significant Market Growth
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness About Nerve Monitoring Among Healthcare Professionals
    • 4.1.3. Opportunity
      • 4.1.3.1. Increase in the Cases of Nerve-Related Disorders
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Monitors*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Stimulation Devices
  • 7.4. Nerve monitoring Electrodes
  • 7.5. Probes

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Evoked Potential(EP)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Electromyography (EMG)
  • 8.4. Electroencephalography (EEG)
  • 8.5. Electrocorticography (ECOG)

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Neurosurgery *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Spine Surgery
  • 9.4. ENT Surgery
  • 9.5. Cardiovascular Applications
  • 9.6. Other Applications

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Surgical Centers
  • 10.4. Ambulatory Surgical Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Nuvasive
  • 13.3. NihonKohden
  • 13.4. CheckPoint Surgicals
  • 13.5. Natus
  • 13.6. Inomed
  • 13.7. Magstim
  • 13.8. Neurowave Systems
  • 13.9. Axontronic
  • 13.10. Xavant Technologies

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us